No-Reflow Prediction in Acute Coronary Syndrome During Percutaneous Coronary Intervention: The NORPACS Risk Score

L. Dawson; Muhammad Rashid; Diem Dinh; Angela Brennan; Jason Bloom; Sinjini Biswas; Jeffrey Lefkovits; J. Shaw; William Chan; David Clark; Ernesto Oqueli; C. Hiew; Melanie Freeman; Andrew J. Taylor; Christopher M. Reid; Andrew E. Ajani; David M. Kaye; Mamas A. Mamas; Dion Stub

doi:10.1161/circinterventions.123.013738

Ask about this paper

Answers are grounded in this paper and cite their sources.

Abstract

Suboptimal coronary reperfusion (no reflow) is common in acute coronary syndrome percutaneous coronary intervention (PCI) and is associated with poor outcomes. We aimed to develop and externally validate a clinical risk score for angiographic no reflow for use following angiography and before PCI.

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Dawson et al. (2024) studied this question.

synapsesocial.com/papers/68e73cb8b6db6435876b61e6 https://doi.org/10.1161/circinterventions.123.013738

View at Publisher

Ask AI

Bookmark

Share

No-Reflow Prediction in Acute Coronary Syndrome During Percutaneous Coronary Intervention: The NORPACS Risk Score

Ask about this paper

Abstract

Discussion

Cite This Study

No-Reflow Prediction in Acute Coronary Syndrome During Percutaneous Coronary Intervention: The NORPACS Risk Score

Ask about this paper

Abstract

Discussion

Cite This Study

Keep reading

Keep reading